Movatterモバイル変換

[0]ホーム
URL:

IN2012DN01328A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01328A
IN2012DN01328AIN1328DEN2012AIN2012DN01328AIN 2012DN01328 AIN2012DN01328 AIN 2012DN01328AIN 1328DEN2012 AIN1328DEN2012 AIN 1328DEN2012AIN 2012DN01328 AIN2012DN01328 AIN 2012DN01328A
Authority
IN
India
Prior art keywords
rsv
protein
treatment
methods
immunospecifically bind
Prior art date
Application number
Inventor
Robert Anthony Williamson
Jehangir Wadia
Gabriel Pascual
Elissa Keogh
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland BvfiledCriticalCrucell Holland Bv
Publication of IN2012DN01328ApublicationCriticalpatent/IN2012DN01328A/en

Links

Classifications

Landscapes

Abstract

Provided herein are antibodies or antigen-binding fragments thereof that immunospecifically bind to the fusion (F) protein of Respiratory Syncytial Virus (RSV). Also provided are methods for of prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of RSV-mediated disease. Methods of generating antibodies that immunospecifically bind RSV F protein also are provided.
IN1328DEN20122009-08-132010-08-13IN2012DN01328A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US27439509P2009-08-132009-08-13
PCT/US2010/045549WO2011020079A1 (en)2009-08-132010-08-13Antibodies against human respiratory syncytial virus (rsv) and methods of use

Publications (1)

Publication NumberPublication Date
IN2012DN01328Atrue IN2012DN01328A (en)2015-06-05

Family

ID=43014487

Family Applications (1)

Application NumberTitlePriority DateFiling Date
IN1328DEN2012IN2012DN01328A (en)2009-08-132010-08-13

Country Status (18)

CountryLink
US (2)US8568719B2 (en)
EP (1)EP2464664B1 (en)
JP (1)JP5762408B2 (en)
KR (1)KR101778317B1 (en)
CN (1)CN102656189B (en)
BR (1)BR112012003064B8 (en)
CA (1)CA2770737C (en)
DK (1)DK2464664T3 (en)
EA (1)EA023179B1 (en)
ES (1)ES2553440T3 (en)
IL (1)IL217977A (en)
IN (1)IN2012DN01328A (en)
MX (1)MX2012001882A (en)
NZ (1)NZ597996A (en)
PL (1)PL2464664T3 (en)
SG (1)SG178335A1 (en)
WO (1)WO2011020079A1 (en)
ZA (1)ZA201201007B (en)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
IN2012DN01328A (en)2009-08-132015-06-05Crucell Holland Bv
EP2591000B1 (en)2010-07-092017-05-17Janssen Vaccines & Prevention B.V.Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
US8956859B1 (en)2010-08-132015-02-17Aviex Technologies LlcCompositions and methods for determining successful immunization by one or more vaccines
PT2710033T (en)2011-05-172021-03-11Univ RockefellerHuman immunodeficiency virus neutralizing antibodies and methods of use thereof
WO2013000982A1 (en)*2011-06-272013-01-03VivalisMethod for screening cells
WO2013006544A1 (en)*2011-07-062013-01-10Medimmune, LlcMethods for making multimeric polypeptides
AU2012362378B2 (en)*2011-12-272016-06-23Dcb-Usa LlcLight chain-bridged bispecific antibody
WO2013135655A1 (en)*2012-03-132013-09-19Universiteit Utrecht Holding B.V.Bi-specific adapters
DK2828293T3 (en)*2012-03-202018-01-08Humabs Biomed S A ANTIBODIES NEUTRALIZING RSV, MPV AND PVM AND USE THEREOF
EP3838923B1 (en)2012-08-242024-05-01The Regents of The University of CaliforniaAntibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis
CN103048459B (en)*2012-12-052014-08-20中国科学院武汉病毒研究所Immune detection reagent for detecting respiratory syncytial virus
RS62304B1 (en)2013-03-142021-09-30Macrogenics Inc BISPECIFIC MOLECULES WHICH ARE IMMUNOREACTIVE WITH IMMUNE EFFECTIVE CELLS EXPRESSING AN ACTIVATING RECEPTOR
TWI659968B (en)2013-03-142019-05-21再生元醫藥公司Human antibodies to respiratory syncytial virus f protein and methods of use thereof
TR201902513T4 (en)2013-04-252019-03-21Janssen Vaccines & Prevention Bv Stabilized soluble prefusion RSV F polypeptides.
EP3010931B1 (en)2013-06-172018-06-13Janssen Vaccines & Prevention B.V.Stabilized soluble pre-fusion rsv f polypeptides
DK3012633T3 (en)*2013-06-212018-08-13Alfresa Pharma Corp Immunochromatography device for detection of RSV
US10047145B2 (en)2013-07-242018-08-14Humabs Biomed SaAntibodies that potently neutralize RSV and uses thereof
PL3068417T3 (en)*2013-11-152024-05-13F.Hoffmann-La Roche AgMethods for viral inactivation using eco-friendly detergents
CN103911389A (en)*2014-04-092014-07-09南昌大学Preparation method of G and F protein for detecting human respiratory syncytial virus antibody
ZA201608812B (en)2014-06-262019-08-28Janssen Vaccines & Prevention BvAntibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
SG11201610446XA (en)2014-06-262017-01-27Janssen Vaccines & Prevention BvAntibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
CN105319373B (en)*2014-08-182017-01-18董俊Rapid human respiratory syncytial virus detection method and kit based on magnetic separating and quantum dot labeling
BR112017006515A8 (en)2014-09-292018-02-27Univ Duke bispecific molecules, compositions, method for treating or preventing HIV-1 infection in an individual with this need, and vector
KR20170093120A (en)*2014-10-102017-08-14아블린쓰 엔.브이.Methods of treating rsv infections
US20180185404A1 (en)*2015-07-022018-07-05Spring Bank Pharmaceuticals, Inc.Compositions and methods for the treatment of viral infection
CA2991540A1 (en)2015-07-072017-01-12Janssen Vaccines & Prevention B.V.Stabilized soluble pre-fusion respiratory syncytial sirus polypeptides
ES2839880T3 (en)2015-07-072021-07-06Janssen Vaccines & Prevention Bv RSV vaccine
JO3555B1 (en)2015-10-292020-07-05Merck Sharp & Dohme An antibody that inactivates the human pneumonia virus
CN106496324B (en)2015-11-302020-01-14天津昊免生物技术有限公司Fully human antibody for resisting respiratory syncytial virus
CN109232737A (en)*2016-03-012019-01-18苏州博泰神州生物技术有限公司A kind of full human monoclonal antibody for RSV attachment G protein surface antigen
CN105753981B (en)*2016-03-082019-10-08湖北工业大学The immune chromatography reagent kit of anti-human Respiratory Syncytial Virus(RSV) N protein antibody and the application antibody
EP3439694A1 (en)2016-04-052019-02-13Janssen Vaccines & Prevention B.V.Vaccine against rsv
PT3439672T (en)2016-04-052021-02-24Janssen Vaccines & Prevention BvStabilized soluble pre-fusion rsv f proteins
US11084796B2 (en)*2016-05-102021-08-10Georgia State University Research Foundation, Inc.Heterocyclic derivatives for the treatment of RSV
KR102421049B1 (en)2016-05-302022-07-15얀센 백신스 앤드 프리벤션 비.브이. Stabilized pre-fusion RSV F protein
WO2018005519A2 (en)2016-06-272018-01-04The Regents Of The University Of CaliforniaCancer treatment combinations
EP3528840A1 (en)*2016-10-212019-08-28Adimab, LLCAnti-respiratory syncytial virus antibodies, and methods of their generation and use
WO2018150029A1 (en)*2017-02-172018-08-23Institut PasteurGeneration of monoclonal antibodies targeting respiratory syncytial virus (rsv) using regulatory b cells from newborns (nbregs)
US11229692B2 (en)2017-05-172022-01-25Janssen Vaccines & Prevention B.V.Methods and compositions for inducing protective immunity against RSV infection
KR20200053518A (en)2017-09-152020-05-18얀센 백신스 앤드 프리벤션 비.브이. Method for safe induction of immunity to RSV
SG11202104522UA (en)2018-11-132021-05-28Janssen Vaccines & Prevention BvStabilized pre-fusion rsv f proteins
WO2020124846A1 (en)*2018-12-182020-06-25珠海泰诺麦博生物技术有限公司Neutralizing antibody against respiratory syncytial virus and use thereof
CL2018003869A1 (en)2018-12-282021-01-15Univ Pontificia Catolica Chile Monoclonal antibodies specific for human parainfluenza virus chimeric protein I (piv), nucleotide sequences; PIV infection diagnostic method and kit
EP3969045A1 (en)2019-05-152022-03-23Janssen Vaccines & Prevention B.V.Prophylactic treatment of respiratory syncytial virus infection with an adenovirus based vaccine
WO2020229577A1 (en)2019-05-152020-11-19Janssen Vaccines & Prevention B.V.Co-administration of seasonal influenza vaccine and an adenovirus based respiratory syncytial virus vaccine
US20220308055A1 (en)*2019-08-272022-09-29University Of Central Florida Research Foundation, Inc.Method and device for pathogen or antibody detection using unmodified signaling substances with or without unlabeled detection reagents
CN111166881B (en)*2020-01-062023-03-24国药中生生物技术研究院有限公司Recombinant respiratory syncytial virus multi-epitope chimeric vaccine and preparation method and application thereof
EP4126023A1 (en)2020-04-022023-02-08Janssen Vaccines & Prevention B.V.Stabilized vaccine compositions
AU2021302535A1 (en)2020-06-292023-02-09Janssen Vaccines & Prevention B.V.Vaccine combination against respiratory syncytial virus infection
CN116113707A (en)*2020-08-312023-05-12基因泰克公司Methods for producing antibodies
FR3114970B1 (en)*2020-10-082023-06-30Univ Tours COMBINATION OF INHALED ANTIBODIES WITH IMMUNO-MODULATING AGENTS FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS
US20240059763A1 (en)*2020-12-182024-02-22Zhuhai Trinomab Pharmaceutical Co., Ltd.Respiratory syncytial virus-specific binding molecule
WO2022175479A1 (en)2021-02-192022-08-25Janssen Vaccines & Prevention B.V.Vaccine combinations against respiratory syncytial virus strain a and b infections
CN113249333B (en)*2021-03-162023-06-02贵州省人民医院 A Hybridoma Cell Line RSVN4C3 Secreting Anti-Respiratory Syncytial Virus Monoclonal Antibody
WO2022268120A1 (en)*2021-06-222022-12-29Biocytogen Pharmaceuticals (Beijing) Co., Ltd.Anti-rsv antibodies and uses thereof
MX2024001867A (en)*2021-08-102024-03-04Icosavax IncVirus-like particle vaccine for respiratory syncytial virus.
WO2025104604A1 (en)2023-11-142025-05-22Janssen Pharmaceuticals, Inc.Anti-respiratory syncytial virus antibodies and uses thereof
CN117924472B (en)*2024-02-042025-02-18北京微星生物科技有限公司Antibodies against respiratory syncytial virus
CN117964750B (en)*2024-02-042024-10-25北京微星生物科技有限公司Monoclonal antibody for resisting respiratory syncytial virus and application thereof

Family Cites Families (145)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4444887A (en)1979-12-101984-04-24Sloan-Kettering InstituteProcess for making human antibody producing B-lymphocytes
US4391904A (en)*1979-12-261983-07-05Syva CompanyTest strip kits in immunoassays and compositions therein
US4714681A (en)1981-07-011987-12-22The Board Of Reagents, The University Of Texas System Cancer CenterQuadroma cells and trioma cells and methods for the production of same
US4474893A (en)*1981-07-011984-10-02The University of Texas System Cancer CenterRecombinant monoclonal antibodies
US4957939A (en)1981-07-241990-09-18Schering AktiengesellschaftSterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4472509A (en)*1982-06-071984-09-18Gansow Otto AMetal chelate conjugated monoclonal antibodies
US4716111A (en)*1982-08-111987-12-29Trustees Of Boston UniversityProcess for producing human antibodies
GB8308235D0 (en)1983-03-251983-05-05Celltech LtdPolypeptides
US4816567A (en)*1983-04-081989-03-28Genentech, Inc.Recombinant immunoglobin preparations
US5807715A (en)*1984-08-271998-09-15The Board Of Trustees Of The Leland Stanford Junior UniversityMethods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US5128326A (en)1984-12-061992-07-07Biomatrix, Inc.Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4751180A (en)*1985-03-281988-06-14Chiron CorporationExpression using fused genes providing for protein product
US4980286A (en)1985-07-051990-12-25Whitehead Institute For Biomedical ResearchIn vivo introduction and expression of foreign genetic material in epithelial cells
US4935233A (en)*1985-12-021990-06-19G. D. Searle And CompanyCovalently linked polypeptide cell modulators
US5225539A (en)*1986-03-271993-07-06Medical Research CouncilRecombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en)1986-03-271986-04-30Winter G PRecombinant dna product
US4946778A (en)1987-09-211990-08-07Genex CorporationSingle polypeptide chain binding molecules
SE459008B (en)1986-09-041989-05-29Bioinvent Int Ab MAKE PRODUCING HUMAN MONOCLONAL ANTIBODIES
EP0307434B2 (en)1987-03-181998-07-29Scotgen Biopharmaceuticals, Inc.Altered antibodies
US4997764A (en)*1987-04-231991-03-05New York UniversityTransformation of human B-lympocytes with Epstein Barr virus and c-myc containing vectors
US5258498A (en)*1987-05-211993-11-02Creative Biomolecules, Inc.Polypeptide linkers for production of biosynthetic proteins
US4880078A (en)1987-06-291989-11-14Honda Giken Kogyo Kabushiki KaishaExhaust muffler
US5336603A (en)1987-10-021994-08-09Genentech, Inc.CD4 adheson variants
DE68921982T4 (en)1988-06-141996-04-25Cetus Oncology Corp COUPLING AGENTS AND STERICALLY DISABLED CONJUGATES THEREOF.
US4925648A (en)1988-07-291990-05-15Immunomedics, Inc.Detection and treatment of infectious and inflammatory lesions
US5601819A (en)1988-08-111997-02-11The General Hospital CorporationBispecific antibodies for selective immune regulation and for selective immune cell binding
US5223409A (en)1988-09-021993-06-29Protein Engineering Corp.Directed evolution of novel binding proteins
EP1541682A3 (en)1988-09-022005-07-06Dyax Corp.Generation and selection of recombinant varied binding proteins
SE461985B (en)1988-09-131990-04-23Bioinvent Int Ab IN VITRO IMMUNIZATION OF Lymphocyte-containing CELL POPULATIONS AND MATERIAL KIT
KR900005995A (en)1988-10-311990-05-07우메모또 요시마사 Modified Interleukin-2 and Method of Making the Same
US5530101A (en)1988-12-281996-06-25Protein Design Labs, Inc.Humanized immunoglobulins
EP0394827A1 (en)1989-04-261990-10-31F. Hoffmann-La Roche AgChimaeric CD4-immunoglobulin polypeptides
ZA902949B (en)1989-05-051992-02-26Res Dev FoundationA novel antibody delivery system for biological response modifiers
ATE144793T1 (en)1989-06-291996-11-15Medarex Inc BISPECIFIC REAGENTS FOR AIDS THERAPY
US5112946A (en)*1989-07-061992-05-12Repligen CorporationModified pf4 compositions and methods of use
NL8902087A (en)1989-08-171991-03-18Stichting Tech Wetenschapp NON-NATURALLY AVOIDING PSEUDORABIES VIRUS AND VACCINES CONTAINING THIS.
US5436146A (en)1989-09-071995-07-25The Trustees Of Princeton UniversityHelper-free stocks of recombinant adeno-associated virus vectors
WO1991006570A1 (en)1989-10-251991-05-16The University Of MelbourneHYBRID Fc RECEPTOR MOLECULES
AU642932B2 (en)1989-11-061993-11-04Alkermes Controlled Therapeutics, Inc.Protein microspheres and methods of using them
EP0434879A1 (en)1989-12-141991-07-03Schering-PloughMethod of making factor dependent human B cell lines
GB8928874D0 (en)1989-12-211990-02-28Celltech LtdHumanised antibodies
US5780225A (en)1990-01-121998-07-14StratageneMethod for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
WO1991010737A1 (en)1990-01-111991-07-25Molecular Affinities CorporationProduction of antibodies using gene libraries
DK0463151T3 (en)1990-01-121996-07-01Cell Genesys Inc Generation of xenogenic antibodies
US5314995A (en)1990-01-221994-05-24OncogenTherapeutic interleukin-2-antibody based fusion proteins
ATE158615T1 (en)1990-03-201997-10-15Univ Columbia CHIMERIC ANTIBODIES WITH RECEPTOR-BINDING LIGANDS IN PLACE OF THEIR CONSTANT REGION
US5427908A (en)*1990-05-011995-06-27Affymax Technologies N.V.Recombinant library screening methods
US5349053A (en)*1990-06-011994-09-20Protein Design Labs, Inc.Chimeric ligand/immunoglobulin molecules and their uses
GB9015198D0 (en)1990-07-101990-08-29Brien Caroline J OBinding substance
US5698426A (en)1990-09-281997-12-16Ixsys, IncorporatedSurface expression libraries of heteromeric receptors
WO1992006180A1 (en)1990-10-011992-04-16University Of ConnecticutTargeting viruses and cells for selective internalization by cells
CA2093022C (en)1990-10-052005-02-22Michael W. FangerTargeted immunostimulation with bispecific reagents
EP0557300B1 (en)1990-10-291997-11-19Chiron CorporationBispecific antibodies, method of production, and uses thereof
DK0574395T3 (en)1990-11-092002-10-07Stephen D Gillies Cytokine immunoconjugates
ES2113940T3 (en)1990-12-031998-05-16Genentech Inc ENRICHMENT METHOD FOR PROTEIN VARIANTS WITH ALTERED UNION PROPERTIES.
JP3242916B2 (en)*1990-12-142001-12-25セル ジェネシス，インコーポレイティド Chimeric chains for receptor-related signal transduction systems
DE69233750D1 (en)*1991-04-102009-01-02Scripps Research Inst Libraries of heterodimeric receptors using phagemids
ES2093778T3 (en)*1991-04-261997-01-01Surface Active Ltd NEW ANTIBODIES AND METHODS FOR USE.
ES2181673T3 (en)1991-05-012003-03-01Jackson H M Found Military Med PROCESS OF TREATMENT OF INFECTIOUS RESPIRATORY DISEASES.
DE69231736T2 (en)1991-05-142001-10-25The Immune Response Corp., Carlsbad TARGETED DELIVERY OF GENES ENCODING IMMUNOGENIC PROTEINS
DE69233482T2 (en)1991-05-172006-01-12Merck & Co., Inc. Method for reducing the immunogenicity of antibody variable domains
ATE195656T1 (en)1991-06-052000-09-15Univ Connecticut TARGETED RELEASE OF GENES ENCODING SECRETORY PROTEINS
WO1992022324A1 (en)1991-06-141992-12-23Xoma CorporationMicrobially-produced antibody fragments and their conjugates
US5844095A (en)1991-06-271998-12-01Bristol-Myers Squibb CompanyCTLA4 Ig fusion proteins
US6136310A (en)*1991-07-252000-10-24Idec Pharmaceuticals CorporationRecombinant anti-CD4 antibodies for human therapy
ES2136092T3 (en)1991-09-231999-11-16Medical Res Council PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES.
US5262522A (en)1991-11-221993-11-16Immunex CorporationReceptor for oncostatin M and leukemia inhibitory factor
ES2227512T3 (en)1991-12-022005-04-01Medical Research Council PRODUCTION OF ANTIBODIES AGAINST SELF-ANTIGENS FROM REPERTORIES OF ANTIBODY SEGMENTS FIXED IN A PHOTO.
US5824307A (en)*1991-12-231998-10-20Medimmune, Inc.Human-murine chimeric antibodies against respiratory syncytial virus
AU3434393A (en)1992-01-171993-08-03Regents Of The University Of Michigan, TheTargeted virus
US5622929A (en)*1992-01-231997-04-22Bristol-Myers Squibb CompanyThioether conjugates
US5667988A (en)1992-01-271997-09-16The Scripps Research InstituteMethods for producing antibody libraries using universal or randomized immunoglobulin light chains
ATE239506T1 (en)1992-03-052003-05-15Univ Texas USE OF IMMUNOCONJUGATES FOR THE DIAGNOSIS AND/OR THERAPY OF VASCULARIZED TUMORS
US5912015A (en)*1992-03-121999-06-15Alkermes Controlled Therapeutics, Inc.Modulated release from biocompatible polymers
US5733743A (en)*1992-03-241998-03-31Cambridge Antibody Technology LimitedMethods for producing members of specific binding pairs
US5447851B1 (en)*1992-04-021999-07-06Univ Texas System Board OfDna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
CA2133411A1 (en)1992-04-031993-10-14Alexander T. YOUNGGene therapy using targeted viral vectors
US5639641A (en)1992-09-091997-06-17Immunogen Inc.Resurfacing of rodent antibodies
ES2191016T3 (en)1992-09-162003-09-01Scripps Research Inst HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES FOR THE SYNCTIAL RESPIRATORY VIRUS.
US6685942B1 (en)1993-12-102004-02-03The Scripps Research InstituteHuman neutralizing monoclonal antibodies to respiratory syncytial virus
DE69330167T2 (en)1992-10-092001-11-15Advanced Tissue Sciences, Inc. LIVER RESERVE CELLS
JPH08503855A (en)1992-12-031996-04-30ジェンザイム・コーポレイション Gene therapy for cystic fibrosis
US5359681A (en)*1993-01-111994-10-25University Of WashingtonFiber optic sensor and methods and apparatus relating thereto
US5934272A (en)1993-01-291999-08-10Aradigm CorporationDevice and method of creating aerosolized mist of respiratory drug
EP0619323A1 (en)1993-04-091994-10-12Schering-PloughHuman monoclonal antibodies and processes and materials for making such antibodies
US5457035A (en)*1993-07-231995-10-10Immunex CorporationCytokine which is a ligand for OX40
AU696293B2 (en)1993-12-081998-09-03Genzyme CorporationProcess for generating specific antibodies
ATE300610T1 (en)1994-01-312005-08-15Univ Boston LIBRARIES OF POLYCLONAL ANTIBODIES
US5837458A (en)1994-02-171998-11-17Maxygen, Inc.Methods and compositions for cellular and metabolic engineering
US5834252A (en)*1995-04-181998-11-10Glaxo Group LimitedEnd-complementary polymerase reaction
US5605793A (en)1994-02-171997-02-25Affymax Technologies N.V.Methods for in vitro recombination
US5516637A (en)*1994-06-101996-05-14Dade International Inc.Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
GB9415379D0 (en)1994-07-291994-09-21Smithkline Beecham PlcNovel compounds
JPH10503371A (en)1994-07-291998-03-31スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー New compound
WO1996006641A1 (en)1994-08-291996-03-07Prizm Pharmaceuticals, Inc.Conjugates of vascular endothelial growth factor with targeted agents
EP0805628B1 (en)1995-01-172003-05-02Brigham And Women's Hospital, Inc.Receptor specific transepithelial transport of immunogens
US6030613A (en)1995-01-172000-02-29The Brigham And Women's Hospital, Inc.Receptor specific transepithelial transport of therapeutics
US5731168A (en)*1995-03-011998-03-24Genentech, Inc.Method for making heteromultimeric polypeptides
US6019968A (en)*1995-04-142000-02-01Inhale Therapeutic Systems, Inc.Dispersible antibody compositions and methods for their preparation and use
ATE390933T1 (en)1995-04-272008-04-15Amgen Fremont Inc HUMAN ANTIBODIES AGAINST IL-8 DERIVED FROM IMMUNIZED XENOMICES
WO1996034096A1 (en)1995-04-281996-10-31Abgenix, Inc.Human antibodies derived from immunized xenomice
US5811524A (en)*1995-06-071998-09-22Idec Pharmaceuticals CorporationNeutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
AU710347B2 (en)*1995-08-311999-09-16Alkermes Controlled Therapeutics, Inc.Composition for sustained release of an agent
US5840300A (en)1995-09-111998-11-24Trustees Of The University Of PennsylvaniaMethods and compositions comprising single chain recombinant antibodies
WO1997010846A1 (en)*1995-09-181997-03-27Intracel CorporationNeutralizing monoclonal antibodies to respiratory syncytial virus
GB9601081D0 (en)1995-10-061996-03-20Cambridge Antibody TechSpecific binding members for human transforming growth factor beta;materials and methods
US5723125A (en)1995-12-281998-03-03Tanox Biosystems, Inc.Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
JP2978435B2 (en)*1996-01-241999-11-15チッソ株式会社 Method for producing acryloxypropyl silane
WO1997032572A2 (en)1996-03-041997-09-12The Penn State Research FoundationMaterials and methods for enhancing cellular internalization
WO1997034631A1 (en)1996-03-181997-09-25Board Of Regents, The University Of Texas SystemImmunoglobin-like domains with increased half lives
US5985309A (en)*1996-05-241999-11-16Massachusetts Institute Of TechnologyPreparation of particles for inhalation
US5855913A (en)1997-01-161999-01-05Massachusetts Instite Of TechnologyParticles incorporating surfactants for pulmonary drug delivery
US5874064A (en)*1996-05-241999-02-23Massachusetts Institute Of TechnologyAerodynamically light particles for pulmonary drug delivery
US5916771A (en)1996-10-111999-06-29Abgenix, Inc.Production of a multimeric protein by cell fusion method
US20020141990A1 (en)1996-11-012002-10-03Smithkline Beecham CorporationAnti-RSV human monoclonal antibodies
US5842307A (en)1996-11-151998-12-01May; KenzelSelf-adjusting, automatic spot weed sprayer
KR100643058B1 (en)1996-12-032006-11-13아브게닉스, 인크.Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
CA2277801C (en)1997-01-162002-10-15Massachusetts Institute Of TechnologyPreparation of particles for inhalation
TR199902553T2 (en)1997-04-142000-03-21Micromet Gesellschaft F�R Biomedizinische Forschung Mbh New methods and uses for the production of antigen receptors against the human body.
US6235883B1 (en)1997-05-052001-05-22Abgenix, Inc.Human monoclonal antibodies to epidermal growth factor receptor
US5989463A (en)*1997-09-241999-11-23Alkermes Controlled Therapeutics, Inc.Methods for fabricating polymer-based controlled release devices
SE512663C2 (en)1997-10-232000-04-17Biogram Ab Active substance encapsulation process in a biodegradable polymer
HUP9900956A2 (en)1998-04-092002-04-29Aventis Pharma Deutschland Gmbh.Single-chain multiple antigen-binding molecules, their preparation and use
EP1089712B1 (en)1998-06-242003-05-02Advanced Inhalation Research, Inc.Large porous particles emitted from an inhaler
US6472147B1 (en)1999-05-252002-10-29The Scripps Research InstituteMethods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
US7229619B1 (en)2000-11-282007-06-12Medimmune, Inc.Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
EP1265928B1 (en)2000-01-272010-07-21Medimmune, LLCUltra high affinity rsv neutralizing antibodies
US20050175986A1 (en)2000-05-092005-08-11Smit Kline Beecham CorporationHuman monoclonal antibody
US6818216B2 (en)*2000-11-282004-11-16Medimmune, Inc.Anti-RSV antibodies
FR2817875B1 (en)2000-12-072005-03-18Technopharm PROCESS FOR THE PREPARATION OF A HUMAN MONOCLONAL ANTIBODY, FRAGMENTS THEREOF OR ANTIBODIES COMPRISING SUCH FRAGMENTS, THE ANTIBODIES THUS OBTAINED AND THEIR USE
ES2727425T3 (en)2000-12-122019-10-16Medimmune Llc Molecules with prolonged half-lives, compositions and uses thereof
US8188231B2 (en)*2002-09-272012-05-29Xencor, Inc.Optimized FC variants
US7217797B2 (en)*2002-10-152007-05-15Pdl Biopharma, Inc.Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
EP1597280B2 (en)2003-02-262016-08-24Institute for Research in BiomedicineMonoclonal antibody production by ebv transformation of b cells
US7070786B2 (en)2003-06-062006-07-04Centocor, Inc.RSV proteins, antibodies, compositions, methods and uses
JP2007531707A (en)*2003-10-152007-11-08ピーディーエル バイオファーマ， インコーポレイテッド Modification of Fc fusion protein serum half-life by mutagenesis of heavy chain constant region positions 250, 314 and / or 428 of IG
BRPI0417107A (en)2003-12-192007-02-06Genentech Inc antibody fragment, antibody fragment preparation methods, isolated nucleic acid, compositions, host cell, and antibody fragment manufacture and generation methods
AU2005214988A1 (en)2004-02-172005-09-01Absalus, Inc.Super-humanized antibodies against respiratory syncytial virus
TW200636064A (en)*2004-10-282006-10-16Centocor IncAnti-respiratory syncytial virus antibodies, antigens and uses thereof
PT1974020E (en)2005-12-162011-08-26Ribovax Biotechnologies SaMethods for obtaining immortalized antibody secreting cells
CA2678628A1 (en)*2007-03-062008-09-12Symphogen A/SRecombinant antibodies for treatment of respiratory syncytial virus infections
BRPI0817079A2 (en)2007-09-072016-10-11Symphogen As processes for recombinant manufacture of anti-rsv antibodies
BRPI0817257A2 (en)2007-09-242015-06-16Univ Vanderbilt Monoclonal antibodies to respiratory syncytial virus and their uses
IN2012DN01328A (en)2009-08-132015-06-05Crucell Holland Bv
EP2591000B1 (en)*2010-07-092017-05-17Janssen Vaccines & Prevention B.V.Anti-human respiratory syncytial virus (rsv) antibodies and methods of use

Also Published As

Publication numberPublication date
AU2010282312A1 (en)2012-02-23
NZ597996A (en)2014-02-28
CA2770737A1 (en)2011-02-17
BR112012003064B8 (en)2021-05-25
CN102656189A (en)2012-09-05
US20140044719A1 (en)2014-02-13
MX2012001882A (en)2012-04-11
EA201200277A1 (en)2012-09-28
EP2464664A1 (en)2012-06-20
ZA201201007B (en)2019-08-28
SG178335A1 (en)2012-03-29
DK2464664T3 (en)2016-01-18
BR112012003064A2 (en)2017-11-14
IL217977A (en)2016-06-30
US20110076268A1 (en)2011-03-31
BR112012003064B1 (en)2021-03-16
JP5762408B2 (en)2015-08-12
US8568719B2 (en)2013-10-29
EA023179B1 (en)2016-05-31
CN102656189B (en)2014-10-08
PL2464664T3 (en)2016-02-29
ES2553440T3 (en)2015-12-09
US9365638B2 (en)2016-06-14
HK1172350A1 (en)2013-04-19
CA2770737C (en)2020-05-12
WO2011020079A1 (en)2011-02-17
KR20120050480A (en)2012-05-18
EP2464664B1 (en)2015-09-23
KR101778317B1 (en)2017-09-13
IL217977A0 (en)2012-03-29
JP2013501527A (en)2013-01-17

Similar Documents

PublicationPublication DateTitle
IN2012DN01328A (en)
PH12016500859B1 (en)Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
PH12015501558B1 (en)Human antibodies to respiratory syncytial virus f protein and methods of use thereof
GEP20217260B (en)Antibody neutralizing human respiratory syncytial virus
EA201201116A1 (en) MONOCLONAL HUMAN ANTIBODIES OBTAINED FROM HUMAN B-CELLS AND HAVING NEUTRALIZING ACTIVITY AGAINST THE VIRUS AIRFLOWER
MX2010004482A (en)Anti-rsv g protein antibodies.
WO2011071574A3 (en)Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
MX2012000035A (en)Recombinant rsv antigens.
MX337932B (en)Modified rsv f proteins and methods of their use.
WO2010056898A3 (en)Rapid expression cloning of human monoclonal antibodies from memory b cells
TN2010000210A1 (en)Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
MY157564A (en)Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
EA201300131A1 (en) COMBINED PHARMACEUTICAL COMPOSITION AND METHODS FOR THE TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASES OR CONDITIONS
EA201101643A1 (en) OPTIONS FOR THE USE OF IL-1β ANTIBODIES AND THEIR CONNECTING FRAGMENTS IN THE CARDIOVASCULAR SYSTEM
WO2013095091A3 (en)Rsv g protein specific antibodies
MX2009005026A (en)Anti-tsg101 antibodies and their uses for treatment of viral infections.
WO2010117455A3 (en)Human monoclonal antibodies protective against bubonic plaque
WO2012054739A3 (en)Structure-guided identification of binding interactions of human laminin receptor precursor with laminin and identification of compounds that affect binding
UA108207C2 (en) HIGH-AFIN HUMAN ANTIBODY TO HUMAN ANGIOPOETIN-2
HK1180703A1 (en)Anti-n3pglu amyloid beta peptide antibodies and uses thereof
TH156774A (en) Human monoclonal antibodies With specificity for denguexirite 1 E virus proteins and their use (HUMAN MONOCLONAL ANTIBODY WITH SPECIFICITY FOR DENGUE VIRUS SEROTYPE 1 E PROTEIN AND USES THEREOF).
WO2011109104A3 (en)Molecular clone of hiv-1
[8]ページ先頭
©2009-2025 Movatter.jp